Poland Pet Veterinary Diets - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

The poland pet veterinary diets market size was valued at USD 257 million in 2025 and is estimated to grow from USD 285.30 million in 2026 to reach USD 480.70 million by 2031, at a CAGR of 11% during the forecast period (2026-2031). This report is Segmented by Sub Product (Diabetes, Renal, Urinary Tract Disease, Digestive Sensitivity, Oral Care Diets, Derma Diets, and More), by Pets (Cats, Dogs, and Other Pets), and by Distribution Channel (Convenience Stores, Online Channel, Specialty Stores, Supermarkets/Hypermarkets, and Others). The Market Forecasts are Provided in Terms of Value (USD) and Volume (Metric Tons).

Poland Pet Veterinary Diets Market Trends and Insights

Rising Premiumization and Veterinary Grade Product Preference

The Poland pet veterinary diets market is experiencing growth due to a shift toward products associated with measurable health outcomes. Pet owners are increasingly adopting therapeutic feeding as part of treatment plans for chronic conditions. This shift positions these products as less comparable to mainstream pet food and more aligned with clinical needs. For example, Royal Canin’s VMX 2026 therapeutic nutrition initiative demonstrated how suppliers are focusing on structured care and post-diagnosis support. Similarly, Hill's Pet Nutrition Inc. expanded its prescription product portfolio with new condition-specific launches, emphasizing higher-value formulations with a clear medical focus. This trend benefits the Poland pet veterinary diets market by fostering more resilient repeat purchase decisions, as diets linked to disease management hold greater importance than standard premium feeding. Additionally, it enables leading brands to maintain pricing levels, as owners prioritize continuity of care over ingredient quality alone.

Expansion of Clinic Driven Functional Nutrition Recommendations

The Poland pet veterinary diets market continues to rely significantly on veterinarians to translate diagnoses into long-term dietary solutions. When a clinician recommends a specific therapeutic formula, pet owners are generally less inclined to switch diets without further professional advice. According to the updated ACVIM consensus on canine chronic inflammatory enteropathy, in 2024, 38% of affected dogs respond positively to dietary adjustments, underscoring the importance of therapeutic diets in managing digestive health. Digestive conditions remain one of the most common clinical reasons for diet-based interventions. For instance, Farmina Pet Foods' distribution agreement with MWI Animal Health, announced in July 2025, highlights how suppliers are prioritizing clinical channels for therapeutic diet distribution over standard retail strategies. Similarly, VAFO Group strengthened its focus on this approach by organizing the first Brit Nutrition Conference in Poland, which brought together veterinarians, technicians, and students for a structured clinical nutrition forum. The market benefits from this strategy, as trust in veterinary recommendations fosters stronger product adherence than mass advertising.

Premium Price Sensitivity in Mass Market Households

The clearest restraint on the Poland pet veterinary diets market is the price gap between therapeutic products and standard pet food. Chronic-condition diets can remain outside the comfort range of many mass-market households, especially when the feeding plan must continue for months or years. The issue is not that owners reject the medical logic of therapeutic nutrition. The problem is that cost pressure returns after the first purchase and often after the first visible health improvement. This can lead to partial compliance, delayed repeat orders, or full return to cheaper mainstream alternatives. The Poland pet veterinary diets market is exposed because its strongest value lies in sustained use and not in one-time trial. The same pressure is likely to be more visible outside premium urban clusters, where household budgets are tighter and clinic reinforcement is weaker. Until affordability improves through pack architecture, clearer value communication, or stronger follow-up support, price sensitivity will remain a structural drag on market expansion.

Other drivers and restraints analyzed in the detailed report include:

• Growth of Online Refill and Subscription Purchases
• Higher Diagnosis Rates for Chronic Pet Conditions
• Limited Veterinary Prescription Compliance in Non-Urban Areas

Segment Analysis

Digestive sensitivity accounted for 17.7% of the Poland pet veterinary diets market size in 2025, making it the largest sub-product segment. This dominance is attributed to the high prevalence of gastrointestinal disorders and the critical role of diet in first-line management. According to the ACVIM consensus, in 2024, 38% of dogs with chronic inflammatory enteropathy respond positively to food-based treatments, underscoring the clinical importance of digestive therapeutic diets. In 2024, Royal Canin strengthened this segment by introducing five new gastrointestinal diets, including a Hydrolyzed Protein Feline formula designed for long-term management.

Renal diets continue to be a significant segment in the Poland pet veterinary diets market due to the high incidence of chronic kidney disease in senior cats, which necessitates consistent long-term feeding solutions. Meanwhile, oral care diets are projected to grow at a CAGR of 9.0% through 2031, making them the fastest-growing sub-product category. Virbac’s 2024 reformulation of Veterinary HPM Small and Toy introduced an oral health component targeting plaque, tartar, and gum inflammation, supporting the category’s evolution toward specialized dental care.

Companies such as Hill's Pet Nutrition Inc. and Mars Incorporated are driving a shift toward multi-condition therapeutic diets, as evidenced by recent product launches addressing kidney, dermatological, gastrointestinal, diabetes, and weight-management care. This trend reflects the Poland pet veterinary diets market's transition from a narrow focus on staple conditions to a more comprehensive clinical portfolio with precise applications.

Complete Report Scope:

• By Sub Product
  • Milk Bioactives
  • Omega-3 Fatty Acids
  • Probiotics
  • Proteins and Peptides
  • Vitamins and Minerals
  • Other Pet Nutraceuticals
• By Pets
  • Cats
  • Dogs
  • Other Pets
• By Distribution Channel
  • Convenience Stores
  • Online Channel
  • Specialty Stores
  • Supermarkets/Hypermarkets
  • Other Channels

List of Companies Covered in this Report:

• Mars, Incorporated
• Nestlé S.A (Purina)
• Colgate-Palmolive Company (Hill’s Pet Nutrition, Inc.)
• Schell and Kampeter, Inc. (Diamond Pet Foods)
• VAFO Group
• Farmina Pet Foods
• Virbac
• Dechra Pharmaceuticals PLC
• Affinity Petcare S.A.
• BEWITAL Holding GmbH and Co. KG
• General Mills, Inc.
• Biedronka
• Lidl
• Carrefour
• ALDI Poland

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support